Factors influencing mortality in atrial fibrillation. Post hoc analysis of an observational study in outpatients.
BACKGROUND
Whether patients with atrial fibrillation (AF) have an increased mortality compared with the general population is controversially assessed.


METHODS
The mortality of 409 outpatients with AF (36% female, mean age 62 years, 39% paroxysmal AF, 27% lone AF), who were included in a prospective observational study, was compared with the mortality of the general population.


RESULTS
The mortality was 4%/year and constant during the 10 years of follow-up. Age (p<0.0001), heart failure (p=0.0013) and echocardiographically detected reduced left ventricular systolic function (p=0.0353) were independent predictors. The mortality of AF patients was 1.4-fold higher than in the general population, of female 1.5 and of male 1.3. Patients with permanent AF had a 1.5-fold higher and patients with heart failure a 1.7-fold higher mortality than the general population. Patients with lone AF did not differ in the mortality from the general population. The mortality of AF patients was not influenced by the duration of atrial fibrillation.


CONCLUSIONS
The prognosis of AF patients is dependent on the cardiovascular co-morbidity, especially the presence or absence of heart failure.
Stöllberger
Claudia
C
2nd Medical Department, Krankenanstalt Rudolfstiftung, Wien, Austria. claudia.stoellberger@chello.at
Winkler-Dworak
Maria
M
Finsterer
Josef
J
Hartl
Elisabeth
E
Chnupa
Pavel
P
D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000704:Analysis of Variance; D001281:Atrial Fibrillation / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000401:mortality*; D001317:Austria / Q000453:epidemiology; D004452:Echocardiography; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005500:Follow-Up Studies; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D010045:Outpatients; D011237:Predictive Value of Tests; D016016:Proportional Hazards Models; D012189:Retrospective Studies; D012307:Risk Factors; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy
D005343:Fibrinolytic Agents